A study by Romain Ballet found that TIG2 not only mobilizes NK cells but also promotes the migration of a CD8+ T cell subset with NK-like functionality; this plays a crucial role in immune surveillance in the tumor microenvironment, further enhancing TIG2’s antitumor effects [95]. This evidence concerns the gene CD8A and neoplasm.